CMS certification 210011
Saint Agnes Hospital
900 Caton Avenue, Baltimore, MD 21229
Saint Agnes Hospital has a CMS overall rating of 3 out of 5 stars. 55% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1.
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 442 completed surveys, 16% response rate, Oct 2024 – Sep 2025.
How Saint Agnes Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Saint Agnes HospitalThis hospital | 3/5 | 55% | — | 3 better 1 worse |
| Medstar Harbor HospitalSame city | 4/5 | 63% | 3 h 32 min | 3 better |
| Johns Hopkins Bayview Medical CenterSame city | 3/5 | 68% | 5 h 22 min | 5 better |
| Medstar Good Samaritan HospitalSame city | 3/5 | 59% | 4 h 7 min | 5 better |
| Medstar Union Memorial HospitalSame city | 5/5 | 69% | 3 h 38 min | 7 better |
| Sinai Hospital of BaltimoreSame city | 3/5 | 61% | 4 h 17 min | 4 better 6 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Baltimore.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,654 cases | Too few cases | 3.6% | 3.9% |
| Heart attack 93 cases | Too few cases | 10.2% | 11.9% |
| Heart failure 300 cases | Too few cases | 8% | 11.1% |
| Pneumonia 310 cases | Too few cases | 16.1% | 15.2% |
| Stroke 127 cases | Too few cases | 14.1% | 11.9% |
| COPD 206 cases | Too few cases | 9.7% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.96 likely 0.62 – 1.3 | 1 |
| After hip or knee replacement 45 cases | Too few cases | 4% | 4.1% |
| Deaths after a serious but treatable surgical complication 58 cases | No different | 158.08 per 1,000 likely 112.55 per 1,000 – 203.61 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,412 cases | No different | 0.76 per 1,000 likely 0.07 per 1,000 – 1.45 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,917 cases | No different | 0.22 per 1,000 likely 0.01 per 1,000 – 0.44 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 5,151 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.42 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,010 cases | No different | 2.57 per 1,000 likely 1.05 per 1,000 – 4.09 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 402 cases | No different | 1.96 per 1,000 likely 0.3 per 1,000 – 3.62 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 382 cases | No different | 7.15 per 1,000 likely 0 per 1,000 – 14.91 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,035 cases | No different | 3.04 per 1,000 likely 0.88 per 1,000 – 5.21 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 386 cases | No different | 4.86 per 1,000 likely 1.01 per 1,000 – 8.71 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 252 cases | No different | 1.63 per 1,000 likely 0.15 per 1,000 – 3.1 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 986 cases | No different | 1.32 per 1,000 likely 0.34 per 1,000 – 2.3 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.68 likely 0.22 – 1.64 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.45 likely 0.12 – 1.23 | 1 |
| Surgical site infections after colon surgery | No different | 0.3 likely 0.02 – 1.47 | 1 |
| MRSA bloodstream infections | No different | 1.1 likely 0.45 – 2.29 | 1 |
| C. diff intestinal infections | Better | 0.3 likely 0.15 – 0.54 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 98 cases | Too few cases | 13.9% | 14.4% |
| Readmitted after heart failure 265 cases | Too few cases | 20.5% | 21.3% |
| Readmitted after pneumonia 272 cases | Too few cases | 17.2% | 17.3% |
| Readmitted after COPD 226 cases | Too few cases | 19.1% | 20% |
| Readmitted after hip or knee replacement 48 cases | Too few cases | 5.4% | 5.8% |
| Days back in hospital after a heart attack 91 cases | Too few cases | 6.1 days per 100 | — |
| Days back in hospital after heart failure 331 cases | Too few cases | -6.8 days per 100 | — |
| Days back in hospital after pneumonia 323 cases | Too few cases | 36.1 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 132 cases | No different | 12.5 per 1,000 likely 9.2 per 1,000 – 16.7 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 112 cases | No different | 9.4 per 100 likely 6.7 per 100 – 13.1 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 112 cases | No different | 4.7 per 100 likely 3.1 per 100 – 7.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 230 cases | No different | 0.9 likely 0.7 – 1.2 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
306 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 104 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Physician Assistant | 44 |
| Internal Medicine | 38 |
| Emergency Medicine | 33 |
| Nurse Anesthetist, Certified Registered | 14 |
| Health Educator | 11 |
| Nurse Practitioner | 10 |
| Pediatrics | 10 |
| Critical Care Medicine | 9 |
| Surgery | 9 |
| Obstetrics & Gynecology | 8 |
| Pharmacist | 8 |
| Hospitalist | 7 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $190,496
- 2020 $61,110
- 2021 $19,447
- 2022 $67,765
- 2023 $202,210
- 2024 $319,806
- 2025 $264,096
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $49,698 | 18 |
| Debt forgiveness | $1,042 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Genentech, Inc. | $156,960 | 32 |
| AstraZeneca Pharmaceuticals LP | $32,179 | 1 |
| AngioDynamics, Inc. | $30,000 | 1 |
| Sobi, INC | $17,178 | 2 |
| Smith+Nephew, Inc. | $15,637 | 16 |
| Medtronic, Inc. | $4,060 | 1 |
| BeiGene, Ltd. | $2,750 | 2 |
| BeOne Medicines Ltd. | $1,950 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Roche Cancer Screening Collection Study Genentech, Inc. | $156,960 |
| A Phase III, double-blind, placebo-controlled, Randomized, Multicenter, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizu… AstraZeneca Pharmaceuticals LP | $32,179 |
| PACIFICA/PAC203/PAC303 SOBI, INC | $17,178 |
| A Phase 3 Randomized, Open-Label Multicenter Study of Zanubrutinib (BGB-3111) Plus Anti-CD20 Antibodies Versus Lenalidomide Plus Rituximab in Patient… BeiGene, Ltd. · NCT05100862 | $4,700 |
| EXTENDED ACCESS OF MOMELOTINIB FOR SUBJECTS WITH PRIMARY MYELOFIBROSIS GlaxoSmithKline, LLC. | $1,453 |
| C16038 (SWITCH) An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO) in Combination with Lenal… Takeda Pharmaceuticals U.S.A., Inc. | $886 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Saint Agnes Hospital
Is Saint Agnes Hospital a good hospital?
Saint Agnes Hospital has a CMS overall rating of 3 out of 5 stars. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Saint Agnes Hospital?
55% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 442 completed HCAHPS surveys.
Does Saint Agnes Hospital have an emergency room?
Yes. CMS lists emergency services at Saint Agnes Hospital.
Does Saint Agnes Hospital receive money from drug and device companies?
Drug and device makers reported $264,096 in payments to Saint Agnes Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.